Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom
For Investigational Purposes, Nanowear’s app, platform, and server will transmit Dexcom G7 CGM data, offering first-in-the-world, home-based, self-administered, continuous cardiometabolic assessments NEW YORK–(BUSINESS WIRE)–Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software... Read More →
Fujifilm strikes partnership with Us2.ai for AI echocardiography analysis
Us2.ai’s AI-based software is being integrated into Fujifilm’s LISENDO ultrasound systems to expedite cardiology image analysis. Fujifilm is collaborating with Singapore-based company Us2.ai to integrate the company’s AI-based image analysis software into the clinical workflows of the LISENDO 880 and... Read More →
Diagnosing diseases and saving lives with AI featuring IMVARIA
Dr. Joshua Reicher, co-founder and CEO of IMVARIA, initially missed the opportunity to develop a company similar to DraftKings and instead decided to focus on saving lives. As a serial entrepreneur, he has been committed to using artificial intelligence to... Read More →
AtaCor Medical Enrolls First Patients in its ASCEND EV Clinical Study
SAN CLEMENTE, Calif., March 24, 2025 /PRNewswire/ — AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced today that it has initiated its ASCEND EV study. The prospective, non-randomized international study aims to evaluate... Read More →
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience EXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) — Lungpacer Medical today announced the appointment of Kevin Kearney as Chief Commercial Officer (CCO). Kearney brings over 20 years... Read More →
Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
HAYWARD, Calif., March 21, 2025 /PRNewswire/ — Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn’s Chief Transformation Officer, will transition... Read More →
Sibel Health Announces Close of New Series C Financing and New FDA 510(k) Clearance
CHICAGO, March 20, 2025 /PRNewswire/ — Sibel Health, an award-winning medical technology company, is pleased to announce the closing of $30 million in new equity financing and its 7th FDA 510(k) clearance. The equity financing was led by Sibel’s existing... Read More →
Stanford Medicine and LEADOPTIK Announce Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
SAN JOSE, Calif., March 19, 2025 /PRNewswire/ — LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has entered into a research collaboration with Stanford Medicine to explore the use of AI-enhanced real-time optical imaging in lung... Read More →
Moon Surgical gets FDA nod for AI-enhancement for surgical robot
Moon Surgical announced today that it received FDA clearance for ScoPilot, a Nvidia-enabled platform for its Maestro surgical robot. The Paris-based company also announced further integrations with Nvidia technologies, including the Isaac for Healthcare platform. Read More
FDA Grants 510(k) Clearance for Perfusion Pressure on the MY01’s Mobile Application
MONTREAL, QC – March 18, 2025 – MY01, an innovative medical technology company dedicated to transforming the diagnosis of limb perfusion injuries, is excited to announce that the inclusion of Perfusion Pressure, a key physiological indicator for complications like compartment... Read More →